课题基金 / 基金详情

IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances (VITA): A Study to Explore the Feasibility of using Combined Modalities to Test the Safety of CaridMEMS Device in PAH Patients

IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances (VITA): A Study to Explore the Feasibility of using Combined Modalities to Test the Safety of CaridMEMS Device in PAH Patients
IGF::OT::IGF 血管干预/创新和治疗进展 (VITA)：一项探索使用组合方式测试 CaridMEMS 设备在 PAH 患者中安全性的可行性的研究
批准号：
9430244
负责人：
REBECCA PFEIFER
金额：
$5.96万
依托单位：
ALLEGHENY-SINGER RESEARCH INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
项目状态：
已结题
起止时间：
2013-12-01 至 2017-05-31
来源：
https://reporter.nih.gov/project-details/9430244
关键词：
Blood VesselsClinicalClinical assessmentsComputer softwareContractsDevelopmentDevicesDiagnosticDiseaseDisease ProgressionFutureGoalsImaging technologyInterventionLearningModalityMonitorNational Heart, Lung, and Blood InstitutePatientsPulmonary HypertensionRiskSupport ContractsTestingTherapeuticVascular Diseaseshemodynamicsimprovedinnovationmedically underservednovelproduct developmentprognosticprognostic toolprogramspulmonary arterial hypertensionsafety testing

项目摘要

项目成果

REBECCA PFEIFER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Vascular Interventions/Innovations and Therapeutic Advances (VITA) Program is a new translational initiative of the National Heart, Lung, and Blood Institute (NHLBI) that enables and accelerates the development of promising diagnostic and therapeutic modalities for unmet and underserved medical needs. The VITA Program provides contract support for early-stage translational development of product candidates in the fields of vascular disorders, thrombotic diseases, and pulmonary hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data